YorkBridge Wealth Partners’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$308K Sell
1,666
-76
-4% -$13.4K 0.08% 185
2022
Q3
$290K Sell
1,742
-4
-0.2% -$814 0.07% 202
2022
Q2
$360K Sell
1,746
-52
-3% -$11.7K 0.09% 164
2022
Q1
$435K Sell
1,798
-90
-5% -$20.9K 0.1% 160
2021
Q4
$460K Buy
1,888
+64
+4% +$14.6K 0.1% 158
2021
Q3
$373K Buy
1,824
+90
+5% +$19.3K 0.09% 179
2021
Q2
$358K Buy
1,734
+13
+0.8% +$2.62K 0.09% 177
2021
Q1
$328K Buy
+1,721
New +$319K 0.1% 180
2019
Q3
Sell
-995
Closed -$148K 576
2019
Q2
$148K Sell
995
-250
-20% -$33.4K 0.07% 228
2019
Q1
$159K Sell
1,245
-15
-1% -$1.76K 0.07% 197
2018
Q4
$135K Sell
1,260
-89
-7% -$9.94K 0.07% 203
2018
Q3
$154K Sell
1,349
-56
-4% -$6.33K 0.07% 205
2018
Q2
$148K Buy
1,405
+37
+3% +$3.72K 0.06% 218
2018
Q1
$129K Buy
1,368
+83
+6% +$7.55K 0.06% 248
2017
Q4
$113K Buy
+1,285
New +$115K 0.05% 266

Other funds holding STE

YorkBridge Wealth Partners's STE Position: Q4 2022 in Review

YorkBridge Wealth Partners reduced its Steris (STE) stake by 4.4% in Q4 2022, selling an estimated $13.4K and leaving 1,666 shares worth $308K. The position accounts for 0.08% of the portfolio, ranked #185.

YorkBridge Wealth Partners first reported a position in STE in Q4 2017 and has held it in 15 quarters since. The position peaked at $460K in Q4 2021. 648 funds tracked by Wall St. Rank hold STE as of Q4 2022.

  • YorkBridge Wealth Partners held 1,666 shares of Steris worth $308K as of Q4 2022.
  • YorkBridge Wealth Partners sold 76 Steris shares in Q4 2022, an estimated $13.4K.
  • Steris made up 0.08% of YorkBridge Wealth Partners's portfolio in Q4 2022, its #185 holding.
  • YorkBridge Wealth Partners first reported a position in Steris in Q4 2017 and has held it in 15 quarters since.
  • YorkBridge Wealth Partners's Steris position peaked at $460K in Q4 2021.
  • 648 funds tracked by Wall St. Rank held Steris as of Q4 2022.

Based on YorkBridge Wealth Partners's 13F filing for Q4 2022, filed 26 Jan 2023.